000 02052cam  2200361zi 4500
0019.874301
003CaOODSP
00520221107164144
006m     o  d f      
007cr |||||||||||
008190723e201906##onc     o    f000 0 eng d
020 |a9780660312163
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-280/2019E-PDF
24500|aMandatory reporting of serious adverse drug reactions and medical device incidents by hospitals : |bguidance document.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada,|cJune 2019.
264 4|c©2019
300 |a1 online resource (iv, 40 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Déclaration obligatoire des réactions indésirables graves à un médicament et des incidents liés aux instruments médicaux par les hôpitaux : document d’orientation.
500 |aIssued also in HTML format.
520 |a"The purpose of this guidance document is to provide hospitals with information that may be useful in achieving compliance with the federal regulatory requirement for hospitals to report serious ADRs and MDIs to Health Canada as outlined in section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical DeviceRegulations"--Objective, page 1.
69207|2gccst|aHealth care facilities
69207|2gccst|aSide effects
69207|2gccst|aLegislation
7101 |aCanada. |bHealth Canada.
77508|tDéclaration obligatoire des réactions indésirables graves à un médicament et des incidents liés aux instruments médicaux par les hôpitaux : |w(CaOODSP)9.874303
85640|qPDF|s610 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-280-2019-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting/mandatory-hospital-reporting/drugs-devices.html